Published on: June 17, 2019 at 09:30PM
Condition: Type 2 Diabetes
Interventions: Drug: Tirzepatide; Drug: Semaglutide
Sponsor: Eli Lilly and Company
Not yet recruiting
http://bit.ly/2ILODYP
Monday, 17 June 2019
New diabetes clinical trial: A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Nothing happens without a Reason
Make Something out of it.